Track the Lexeo Therapeutics, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €404.5m. The latest transaction was disclosed on 18 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Townsend Richard Nolan. All data is free.
72
Insider Decl.
n/a
Thresholds
€100,050
1 ops.
Buy Volume
€457,907
24 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Lexeo Therapeutics, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$20.30.
40Σ signal
Buys €100,050€457,907 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Lexeo Therapeutics, Inc. es una empresa centrada en el desarrollo de terapias génicas para enfermedades genéticas raras. Pone énfasis en la innovación en soluciones de tratamiento basadas en ADN.